Divi's Laboratories hits 52-week high after strong Q2 results
In short
Divi’s Laboratories shares rose to a new 52-week high after strong Q2 FY27 results. Net profit increased 64% year-on-year to ₹1,127 crore, and revenue climbed 35% to ₹3,676 crore.
Brokerages pointed to growth in custom synthesis and peptides. The strong results helped support the stock’s big year-to-date gain.
What the reporting says
Divi’s Laboratories shares surged to a fresh 52-week high after strong Q2 FY27 results and positive broker commentary. Mint said net profit rose 64% year-on-year to ₹1,127 crore, while revenue grew 35% to ₹3,676 crore. Brokerages highlighted growth potential in custom synthesis and peptides, supporting the stock’s sharp year-to-date rise and bullish sentiment around the company.
Why it matters
Divi’s Laboratories hit a fresh 52-week high after reporting strong Q2 FY27 results. Mint said net profit rose 64% year-on-year to ₹1,127 crore and revenue grew 35% to ₹3,676 crore, while brokerages pointed to custom synthesis and peptides as growth drivers. The move reinforces positive sentiment around the stock and its near-term earnings momentum.